Cargando…

Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma

BACKGROUND: Glioblastoma Multiforme (GBM) is a malignant primary brain tumor in which the standard treatment, ionizing radiation (IR), achieves a median survival of about 15 months. GBM harbors glioblastoma stem-like cells (GSCs), which play a crucial role in therapeutic resistance and recurrence. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hyunkoo, Lee, Sungmin, Kim, Kyeongmin, Jeon, Jaewan, Kang, Seok-Gu, Youn, HyeSook, Kim, Hae Yu, Youn, BuHyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420000/
https://www.ncbi.nlm.nih.gov/pubmed/34488821
http://dx.doi.org/10.1186/s13046-021-02077-4
_version_ 1783748871360348160
author Kang, Hyunkoo
Lee, Sungmin
Kim, Kyeongmin
Jeon, Jaewan
Kang, Seok-Gu
Youn, HyeSook
Kim, Hae Yu
Youn, BuHyun
author_facet Kang, Hyunkoo
Lee, Sungmin
Kim, Kyeongmin
Jeon, Jaewan
Kang, Seok-Gu
Youn, HyeSook
Kim, Hae Yu
Youn, BuHyun
author_sort Kang, Hyunkoo
collection PubMed
description BACKGROUND: Glioblastoma Multiforme (GBM) is a malignant primary brain tumor in which the standard treatment, ionizing radiation (IR), achieves a median survival of about 15 months. GBM harbors glioblastoma stem-like cells (GSCs), which play a crucial role in therapeutic resistance and recurrence. METHODS: Patient-derived GSCs, GBM cell lines, intracranial GBM xenografts, and GBM sections were used to measure mRNA and protein expression and determine the related molecular mechanisms by qRT-PCR, immunoblot, immunoprecipitation, immunofluorescence, OCR, ECAR, live-cell imaging, and immunohistochemistry. Orthotopic GBM xenograft models were applied to investigate tumor inhibitory effects of glimepiride combined with radiotherapy. RESULTS: We report that GSCs that survive standard treatment radiation upregulate Speedy/RINGO cell cycle regulator family member A (Spy1) and downregulate CAP-Gly domain containing linker protein 3 (CLIP3, also known as CLIPR-59). We discovered that Spy1 activation and CLIP3 inhibition coordinately shift GBM cell glucose metabolism to favor glycolysis via two cellular processes: transcriptional regulation of CLIP3 and facilitating Glucose transporter 3 (GLUT3) trafficking to cellular membranes in GBM cells. Importantly, in combination with IR, glimepiride, an FDA-approved medication used to treat type 2 diabetes mellitus, disrupts GSCs maintenance and suppresses glycolytic activity by restoring CLIP3 function. In addition, combining radiotherapy and glimepiride significantly reduced GBM growth and improved survival in a GBM orthotopic xenograft mouse model. CONCLUSIONS: Our data suggest that radioresistant GBM cells exhibit enhanced stemness and glycolytic activity mediated by the Spy1-CLIP3 axis. Thus, glimepiride could be an attractive strategy for overcoming radioresistance and recurrence by rescuing CLIP3 expression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02077-4.
format Online
Article
Text
id pubmed-8420000
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84200002021-09-09 Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma Kang, Hyunkoo Lee, Sungmin Kim, Kyeongmin Jeon, Jaewan Kang, Seok-Gu Youn, HyeSook Kim, Hae Yu Youn, BuHyun J Exp Clin Cancer Res Research BACKGROUND: Glioblastoma Multiforme (GBM) is a malignant primary brain tumor in which the standard treatment, ionizing radiation (IR), achieves a median survival of about 15 months. GBM harbors glioblastoma stem-like cells (GSCs), which play a crucial role in therapeutic resistance and recurrence. METHODS: Patient-derived GSCs, GBM cell lines, intracranial GBM xenografts, and GBM sections were used to measure mRNA and protein expression and determine the related molecular mechanisms by qRT-PCR, immunoblot, immunoprecipitation, immunofluorescence, OCR, ECAR, live-cell imaging, and immunohistochemistry. Orthotopic GBM xenograft models were applied to investigate tumor inhibitory effects of glimepiride combined with radiotherapy. RESULTS: We report that GSCs that survive standard treatment radiation upregulate Speedy/RINGO cell cycle regulator family member A (Spy1) and downregulate CAP-Gly domain containing linker protein 3 (CLIP3, also known as CLIPR-59). We discovered that Spy1 activation and CLIP3 inhibition coordinately shift GBM cell glucose metabolism to favor glycolysis via two cellular processes: transcriptional regulation of CLIP3 and facilitating Glucose transporter 3 (GLUT3) trafficking to cellular membranes in GBM cells. Importantly, in combination with IR, glimepiride, an FDA-approved medication used to treat type 2 diabetes mellitus, disrupts GSCs maintenance and suppresses glycolytic activity by restoring CLIP3 function. In addition, combining radiotherapy and glimepiride significantly reduced GBM growth and improved survival in a GBM orthotopic xenograft mouse model. CONCLUSIONS: Our data suggest that radioresistant GBM cells exhibit enhanced stemness and glycolytic activity mediated by the Spy1-CLIP3 axis. Thus, glimepiride could be an attractive strategy for overcoming radioresistance and recurrence by rescuing CLIP3 expression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02077-4. BioMed Central 2021-09-06 /pmc/articles/PMC8420000/ /pubmed/34488821 http://dx.doi.org/10.1186/s13046-021-02077-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kang, Hyunkoo
Lee, Sungmin
Kim, Kyeongmin
Jeon, Jaewan
Kang, Seok-Gu
Youn, HyeSook
Kim, Hae Yu
Youn, BuHyun
Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
title Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
title_full Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
title_fullStr Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
title_full_unstemmed Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
title_short Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
title_sort downregulated clip3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420000/
https://www.ncbi.nlm.nih.gov/pubmed/34488821
http://dx.doi.org/10.1186/s13046-021-02077-4
work_keys_str_mv AT kanghyunkoo downregulatedclip3inducesradioresistancebyenhancingstemnessandglycolyticfluxinglioblastoma
AT leesungmin downregulatedclip3inducesradioresistancebyenhancingstemnessandglycolyticfluxinglioblastoma
AT kimkyeongmin downregulatedclip3inducesradioresistancebyenhancingstemnessandglycolyticfluxinglioblastoma
AT jeonjaewan downregulatedclip3inducesradioresistancebyenhancingstemnessandglycolyticfluxinglioblastoma
AT kangseokgu downregulatedclip3inducesradioresistancebyenhancingstemnessandglycolyticfluxinglioblastoma
AT younhyesook downregulatedclip3inducesradioresistancebyenhancingstemnessandglycolyticfluxinglioblastoma
AT kimhaeyu downregulatedclip3inducesradioresistancebyenhancingstemnessandglycolyticfluxinglioblastoma
AT younbuhyun downregulatedclip3inducesradioresistancebyenhancingstemnessandglycolyticfluxinglioblastoma